StockData
Medtronic plc logo

Medtronic plc (MDT) stock

MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 18/303% above fair value
$100.72−1.60 (-1.56%)

Close on Nov 18, 2026Market cap $128.83BP/E 24.7Yield 2.82%

Medtronic operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Medtronic's operating income for the twelve months ending Jul 31, 2026 was $6.79B, up 10.9% year over year. For fiscal 2026 it was $6.47B, up 8.6% from the year before. Over ten years it grew 1.9% a year on average. The highest annual figure on record is $6.64B in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2026Apr 24, 2026$6.47B+8.6%
FY2025Apr 25, 2025$5.96B+15.8%
FY2024Apr 26, 2024$5.14B-6.2%
FY2023Apr 28, 2023$5.49B-4.6%
FY2022Apr 29, 2022$5.75B+28.3%
FY2021Apr 30, 2021$4.48B-6.4%
FY2020Apr 24, 2020$4.79B-23.6%
FY2019Apr 26, 2019$6.27B-5.6%
FY2018Apr 27, 2018$6.64B+23.4%
FY2017Apr 28, 2017$5.38B+0.4%
FY2016Apr 29, 2016$5.36B+42.4%
FY2015Apr 24, 2015$3.77B-1.2%
FY2014Apr 25, 2014$3.81B-13.4%
FY2013Apr 26, 2013$4.40B–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$1.76B+22.1%
Q4 FY2026CQ1 2026Apr 24, 2026$1.87B+30.4%
Q3 FY2026CQ4 2025Jan 23, 2026$1.46B-11.1%
Q2 FY2026CQ3 2025Oct 24, 2025$1.69B+5.7%
Q1 FY2026CQ2 2025Jul 25, 2025$1.45B+13.1%
Q4 FY2025CQ1 2025Apr 25, 2025$1.44B+36.4%
Q3 FY2025CQ4 2024Jan 24, 2025$1.65B+11.0%
Q2 FY2025CQ3 2024Oct 25, 2024$1.60B+19.0%
Q1 FY2025CQ2 2024Jul 26, 2024$1.28B+0.8%
Q4 FY2024CQ1 2024Apr 26, 2024$1.05B-32.7%
Q3 FY2024CQ4 2023Jan 26, 2024$1.48B+6.5%
Q2 FY2024CQ3 2023Oct 27, 2023$1.34B-4.6%
Q1 FY2024CQ2 2023Jul 28, 2023$1.27B+12.7%
Q4 FY2023CQ1 2023Apr 28, 2023$1.57B-6.3%
Q3 FY2023CQ4 2022Jan 27, 2023$1.39B-16.1%
Q2 FY2023CQ3 2022Oct 28, 2022$1.40B-10.2%
Q1 FY2023CQ2 2022Jul 29, 2022$1.13B+31.0%
Q4 FY2022CQ1 2022Apr 29, 2022$1.67B+4.1%
Q3 FY2022CQ4 2021Jan 28, 2022$1.66B+29.9%
Q2 FY2022CQ3 2021Oct 29, 2021$1.56B+68.1%
Q1 FY2022CQ2 2021Jul 30, 2021$859.00M+27.6%
Q4 FY2021CQ1 2021Apr 30, 2021$1.61B+407.9%
Q3 FY2021CQ4 2020Jan 29, 2021$1.28B-22.1%
Q2 FY2021CQ3 2020Oct 30, 2020$930.00M-31.2%
Q1 FY2021CQ2 2020Jul 31, 2020$673.00M-54.7%
Q4 FY2020CQ1 2020Apr 24, 2020$316.00M-83.8%
Q3 FY2020CQ4 2019Jan 24, 2020$1.64B+6.3%
Q2 FY2020CQ3 2019Oct 25, 2019$1.35B-12.5%
Q1 FY2020CQ2 2019Jul 26, 2019$1.49B+20.1%
Q4 FY2019CQ1 2019Apr 26, 2019$1.95B+0.9%
Q3 FY2019CQ4 2018Jan 25, 2019$1.54B+7.4%
Q2 FY2019CQ3 2018Oct 26, 2018$1.54B-18.5%
Q1 FY2019CQ2 2018Jul 27, 2018$1.24B-10.6%
Q4 FY2018CQ1 2018Apr 27, 2018$1.93B+14.5%
Q3 FY2018CQ4 2017Jan 26, 2018$1.44B+25.2%
Q2 FY2018CQ3 2017Oct 27, 2017$1.89B+36.8%
Q1 FY2018CQ2 2017Jul 28, 2017$1.38B–
Q4 FY2017CQ1 2017Apr 28, 2017$1.68B–
Q3 FY2017CQ4 2016Jan 27, 2017$1.15B–
Q2 FY2017CQ3 2016Oct 28, 2016$1.39B–

More Medtronic figures

See a number that looks wrong?